EUVIMEDEUVIMED entdecken
Crossref

Exploring the “chemo” in chemoimmunotherapy for triple-negative breast cancer

Ting Liu, Leif W Ellisen

Cancer Cell · 2025

DOI: 10.1016/j.ccell.2025.02.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2025. Verfasst von Ting Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Immunotherapy, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this issue of Cancer Cell, Zhang et al. use single-cell RNA sequencing to compare immune cell dynamics in triple-negative breast cancers treated with the PD-L1 inhibitor atezolizumab plus paclitaxel or nab-paclitaxel. They identify distinct T cell activation patterns and highlight mast cells' role in immune activation exclusively in the nab-paclitaxel combination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsImmunotherapyAntineoplastic Combined Chemotherapy ProtocolsHumansFemalePaclitaxelAntibodies, Monoclonal, HumanizedB7-H1 AntigenAlbumins

Substanzen

PaclitaxelAntibodies, Monoclonal, HumanizedatezolizumabB7-H1 Antigen130-nm albumin-bound paclitaxelAlbumins

Autor:innen und Institutionen

  • Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA.
  • Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA; Harvard Medical School, Boston, MA 02115, USA; Ludwig Center at Harvard, Boston, MA 02115, USA. Electronic address: lellisen@mgh.harvard.edu.

Zitieren

APA

Liu, T., & Ellisen, L. W. (2025). Exploring the “chemo” in chemoimmunotherapy for triple-negative breast cancer. Cancer Cell. https://doi.org/10.1016/j.ccell.2025.02.016

Vancouver

Liu T, Ellisen LW. Exploring the “chemo” in chemoimmunotherapy for triple-negative breast cancer. Cancer Cell. 2025. doi:10.1016/j.ccell.2025.02.016

BibTeX
@article{Liu2025,
  author = {Liu, Ting and Ellisen, Leif W},
  title = {Exploring the “chemo” in chemoimmunotherapy for triple-negative breast cancer},
  journal = {Cancer Cell},
  year = {2025},
  doi = {10.1016/j.ccell.2025.02.016}
}
Kostenlos starten →